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HIV type 2, closely HIV type 1 related retroviruses 
discovered few years later, exhibits in infected individuals 
significantly lower plasma viral loads, causes longer periods 
of asymptomatic infection in patients that survive, without 
treatment, for longer periods compared with HIV-1 patients. 
Determining why HIV-2 is much less pathogenic than HIV-1 
is a current challenge that will increase further our 
understanding of HIV pathogenesis. Several studies indicate 
that host factors could play a role in these differences. One 
of the known host cell restriction factor is the deaminase 
APOBEC3G (A3G). This enzyme belongs to APOBEC3 family 
(A3) and all members have antiviral activity against HIV-1 
suppressed by the viral protein Vif. Our previous studies 
have shown that A3G viral inhibition is less active against 
HIV-2 than HIV-1.1 Moreover, the proteins HIV-2Vif and HIV-
1Vif share only 30% of identity and these viruses showed 
differential replication and capacity for productive infection 
in cell lines, suggesting either different threshold 
requirements for the same cellular factor or the 
involvement of different factors to compensate for Vif1 and 
Vif2 functions.2 In the last decades, in contrast with Vif1-A3 
interactions, Vif2-A3 interactions have been very poorly 
explored. Recently, it was reported that HIV-1 and HIV-2 can 
both target A3 via their Vif proteins but each Vif protein has 
distinct recognition sites to specific targets, namely A3F and 
A3G. Moreover, this work indicate that Vif2 can bind to 
several members of A3 protein family and the sensitivity of 
A3 proteins to Vif2-induced degradation is different from 
the one previously observed with Vif1.3 Comparative studies 
of both viruses and A3 host factors that may affect viral 
infectivity will be useful for understanding the determinants 
of HIV-2 pathogenesis and the differences between HIV-1 
and HIV-2.  
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Our aim is to understand at molecular level what is the role 
of the A3 protein family members in HIV-2 infection and 
compare with HIV-1.  
 
Methods 
A3 members were cloned in the same expression vector 
system, expressing A3 in fusion with 3 HA-tags in C-
terminal.  
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Viral production of HIV-1 is higher than HIV-2 production after 293T cells transfection using the same amounts of 
DNA and infectivity detection system used  has a higher  discriminatory power in HIV-1 infections. 
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Renilla Virus concentration
HIV-2  
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Renilla Virus concentration
HIV-1 
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Virus production in HEK293T cells, protein cell lysates 
detections and infection of TZM-bl cells with HIV-2 and HIV-
1 wild type (wt) and Vif defective (Vif-) virions, produced in 
the absence or presence of different A3 proteins. 
Fig. 1 Differences between production levels of HIV-2 and HIV-1 virions.  A), B) 293T cells were transfected with HIVWT  and HIV Vif- molecular clones, in the presence or absence of several A3 expression vectors in ratio of 1:1 HIV:A3 
(1µg of each DNA). Supernatant viral RNA levels was determined by RT-PCR in Virology Laboratory of Egas Moniz Hospital using specific primers for LTR region of HIV-2 and ENV region of HIV-1. C) TZM-bl Infectivity values  using 
different dilutions of HIV-2 and HIV-1WT . 
A) C) 
Fig. 2 A3 proteins inhibit viral production of HIV-2 (A)(B) and  HIV-1 (C) (D) . pRL.CMV (Renilla expression vector) it wasused  as a transfection efficiency control of  293T producing cells . Values ​​of Renilla activity are presented as n fold 
in relation to cell background (secondary axis). Produced viral levels  (cop/mL) were  normalized with  values of transfection efficiency control determined in the  producing cell lysates for each condition.  
Viral production is affected by the efficiency of transfection and the presence of A3 proteins. In the presence of A3 
proteins the levels of HIV-2Vif- decrease drastically.   
A) B) 
C) D) 
Fig. 3 A) Viral infectivity of HIV-2wt and HIV-2Vif- produced in the presence of different APOBEC. After virus normalization, A3 antiviral effects were evaluated by one cycle infectivity assay in TZM-bl cells. Values ​​are presented as % of 
infectivity relative to viruses produced in the absence of A3, defined as 100% (empty vector was used  as control). Columns and error bars represent average ± SD, respectively (n=2); B) Sensitivity of A3 proteins to Vif2. Western blot of 
A3 proteins in virus-producing cells lysates.  
The restriction factors A3B and A3G inhibit HIV-2 Vif- infections and they were strongly neutralized by Vif2. HIV-2-
producing cells lysates showed sensitivity of A3B and A3G to Vif2-induced degradation.  
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1- Viral production of HIV-1 is higher than HIV-2 production. 
2- Viral production is affected by the efficiency of transfection and the presence of A3.  
3- This effect is more pronounced in HIV-2Vif- productions. 
4- HIV-2 infectivity is strongly inhibited by A3B and A3G and this antiviral effect is efficiently suppressed by Vif2 
protein. 
In the future, we will compare HIV-2 and HIV-1 infectivity using viral stocks produced in the presence of lower 
amounts of A3, to avoid the effect on viral production.   
